A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window LAS VEGAS -- ...
Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...
Genetic test results can be hard to understand and interpret for people without a background in genetics. Investigators at Baylor College of Medicine’s Human Genome Sequencing Center are studying ...
New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing.
Milan, Italy: Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide prescribing in routine care could lead to better outcomes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results